The purpose of this study is to see if the study drug is safe and able to reduce irritability in pediatric patients ages 5-17 with Autism Spectrum Disorder (ASD).
- Must be between ages 5 to 17
- Diagnosed with Autism Spectrum Disorder (ASD)
- High level of irritability due to ASD
- Meets DSM V diagnostic criteria for Autism Spectrum Disorder
Participants in this study will receive all study related medical care and examinations at no cost to them or their insurance.
If you would like to hear more about this trial, or see if you qualify to participate, please contact us at 801.409.2040. You can also reach us via e-mail or by submitting an interest form by clicking the button below.